Medicare and Medicaid
Our work in Medicare and Medicaid
-
Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions
Patients receiving post-discharge care from pharmacists had a 28 percent lower risk of readmission at 30 days and almost 32 percent lower risk at 180 days compared with usual care.
Categorized in -
Enforcement of the Emergency Medical Treatment and Labor Act, 2005 to 2014
In a peer-reviewed longitudinal description of trends in enforcement of the Emergency Medical Treatment and Labor Act (EMTALA), researchers found that more than a quarter of hospitals have been cited under the EMTALA—known as the “anti-dumping law”—in the past decade.
Categorized in -
Four Recommendations to Advance Medicare Delivery System Reform
MACRA assumes a wide range of attractive APM opportunities available to physicians, but the reality is that the opportunities are limited, especially for physicians in specialties outside of primary care.
Categorized in -
What Medicare Advantage’s Success in Delivering Post-Acute Care Means for Medicare Reform
A recent study found Medicare Fee-for-Service and Medicare Advantage patients have hospitalization and post-hospitalization costs and outcomes that are generally different. How do these outcomes translate to policy recommendations?
Categorized in -
Privatized Version of Medicare Saves More Money than Traditional Fee-For-Service
Medicare Advantage costs less and improves patient outcomes, according to a USC-led study
Categorized in -
Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service
According to the study, private Medicare Advantage plans achieve better outcomes at lower costs for post-acute care than Medicare fee-for-service.
Categorized in -
Key Takeaways From the Final MACRA Rule, Plus Remaining Challenges
There are three important takeaways from the Centers for Medicare and Medicaid Services final rule on implementation of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Categorized in -
Comments on CMS’s proposed rule for implementation of MACRA provisions
Paul Ginsburg and his colleagues suggest three ways in which CMS can further achieve its stated goal to “expand the opportunities for participation in APMs” by better supporting providers’ transition under MACRA.
Categorized in -
Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase
For high-cost specialty drug users, lack of an out-of-pocket cap in Part D has eaten savings from donut hole closure.
Categorized in -
Specialty Drug Prices Offset Measures to Lower Medicare Patient Costs
Patients who struggle to pay for their drugs may not take their medicine as prescribed.
Categorized in